Twist Bioscience Corporation Revenue 2017–2025
Twist Bioscience Corporation annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Twist Bioscience Corporation revenue for the quarter ending March 31, 2026 was 110.7 M, a 19.31% increase year-over-year.
- Twist Bioscience Corporation revenue for the twelve months ending March 31, 2026 was 403.3 M, a 27.22% increase year-over-year.
- Twist Bioscience Corporation annual revenue for 2025 was 376.6 M, a 20.32% increase from 2024.
- Twist Bioscience Corporation annual revenue for 2024 was 313.0 M, a 27.69% increase from 2023.
- Twist Bioscience Corporation annual revenue for 2023 was 245.1 M, a 20.41% increase from 2022.
- Twist Bioscience Corporation annual revenue for 2022 was 203.6 M.
Twist Bioscience Corporation (TWST) — Frequently Asked Questions
Twist Bioscience Corporation (TWST) is a publicly traded US company. It has a market capitalization of $4.11B. In fiscal 2025 it reported revenue of $377M and net income of -$78M. Explore TWST's stock price, financial statements, earnings history, margins and key ratios below.
What is Twist Bioscience Corporation's market cap?
Twist Bioscience Corporation (TWST) has a market capitalization of $4.11B.
What is the TWST stock price?
TWST trades at $68.66 (+1.31% on the day).
How much revenue does Twist Bioscience Corporation make?
Twist Bioscience Corporation reported revenue of $377M in fiscal 2025.
Is TWST profitable?
In fiscal 2025, Twist Bioscience Corporation reported net income of -$78M.